Geode Capital Management
EXOZ icon

Geode Capital Management’s eXoZymes Inc EXOZ Stock Holding History

Geode Capital Management’s Portfolio EXOZ Stock Details EXOZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$135K Sell
23,263
-143
-0.6% -$886 ﹤0.01% 3982
2026
Q2 		$197K Buy
23,406
+1,515
+7% +$14.3K ﹤0.01% 3923
2026
Q1 		$164K Sell
21,891
-1,671
-7% -$15.3K ﹤0.01% 3986
2025
Q4 		$257K Buy
23,562
+499
+2% +$6.88K ﹤0.01% 3827
2025
Q3 		$340K Buy
23,063
+2,464
+12% +$26.8K ﹤0.01% 3746
2025
Q2 		$198K Buy
20,599
+3
+0% +$37 ﹤0.01% 3877
2025
Q1 		$215K Buy
20,596
+3,832
+23% +$56.9K ﹤0.01% 3825
2024
Q4 		$277K Buy
+16,764
New +$248K ﹤0.01% 3795

Other funds holding EXOZ

Davidson Kahn Capital Management
Davidson Kahn Capital Management Sherman Oaks, California $253M AUM 9.56% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

Geode Capital Management's EXOZ Position: Q3 2026 in Review

Geode Capital Management reduced its eXoZymes Inc (EXOZ) stake by 0.61% in Q3 2026, selling an estimated $886 and leaving 23,263 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #3982.

Geode Capital Management first reported a position in EXOZ in Q4 2024 and has held it in 8 quarters since. The position peaked at $340K in Q3 2025. 4 funds tracked by Wall St. Rank hold EXOZ as of Q3 2026.

  • Geode Capital Management held 23,263 shares of eXoZymes Inc worth $135K as of Q3 2026.
  • Geode Capital Management sold 143 eXoZymes Inc shares in Q3 2026, an estimated $886.
  • eXoZymes Inc made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #3982 holding.
  • Geode Capital Management first reported a position in eXoZymes Inc in Q4 2024 and has held it in 8 quarters since.
  • Geode Capital Management's eXoZymes Inc position peaked at $340K in Q3 2025.
  • 4 funds tracked by Wall St. Rank held eXoZymes Inc as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.